CoChat

Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression

Open access
Gacias, Mar, Gerona-Navarro, Guillermo, Plotnikov, Alexander N., Zhang, Guangtao, Zeng, Lei, Kaur, Jasbir, Moy, Gregory, Rusinova, Elena, Rodriguez, Yoel, Matikainen, Bridget, Vincek, Adam, Joshua, Jennifer, Casaccia, Patrizia, Zhou, Ming-Ming · 2014 · Chemistry & Biology
Cited by 155

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

SUMMARY Lysine acetylation regulates gene expression through modulating protein-protein interactions in chromatin. Chemical inhibition of acetyl-lysine binding bromodomains of the major chromatin regulators BET (bromodomain and extra-terminal domain) proteins, has been shown to effectively block cell proliferation in cancer and inflammation. However, whether selective inhibition of individual BET bromodomains has distinctive functional consequences, remains only partially understood. In this study, we show that selective chemical inhibition of the first bromodomain of BET proteins using our newly designed small molecule inhibitor, Olinone, accelerated the progression of mouse primary oligodendrocyte progenitors towards differentiation, while inhibition of both bromodomains of BET proteins hindered differentiation. This effect was target-specific, as it was not detected in cells treated with inactive analogues and independent of any effect on proliferation. Therefore, selective chemical modulation of individual bromodomains, rather than use of broad-based inhibitors may enhance regenerative strategies in disorders characterized by myelin loss such as aging and neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2014.05.009

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Selective inhibition of BET bromodomains

    Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 4×

    “…even as compared to the recently developed: MS436, a diazobenzene compound (Zhang et al., 2013), or BETspecific BrDi, MS417, which is a thienotriazolo-diazepine compound (Zhang et al., 2012b) and structurally related to (+)-JQ1 (Filippakopoulos et al., 2010) and I-BET (Nicodeme et al., 2010).”
    BackgroundInfluential
  • RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

    Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 2×

    “, 2010), acute myeloid leukemia (Zuber et al., 2011), MLL-fusion leukemia (Dawson et al.”
    Background
  • Structure and ligand of a histone acetyltransferase bromodomain

    Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732 · cited 1×

    “The evolutionarily conserved bromodomain (BrD) functions as the acetyl-lysine binding domain (Dhalluin et al., 1999) for acetylated histones and transcription factors, which is required for ordered gene transcription in chromatin (Sanchez and Zhou, 2009).”
    BackgroundSelf-citation
  • Suppression of inflammation by a synthetic histone mimic

    Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 3×

    “It is important to note that Olinone is the first reported bromodomain inhibitor (BrDi) with a superior selectivity between the two bromodomains of BET proteins, even as compared to the recently developed: MS436, a diazobenzene compound (Zhang et al., 2013), or BETspecific BrDi, MS417, which is a thienotriazolo-diazep…”
    Background
  • HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction

    Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-H., Bu, H., Hu, T., Taketo, M. M., van Es, J. H., Clevers, H., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2333 · Cited by 559 · cited 1×

    “In this lineage, the early progenitor stage is characterized by global protein lysine acetylation and decreased global histone acetylation, was previously identified as critical for the proper onset of oligodendrocyte differentiation (Shen et al., 2008; Wu et al., 2012; Ye et al., 2009).”
    Background

Show all 5 references

Cited by

See all 155

Metadata

Authors
Gacias, M., Gerona-Navarro, G., Plotnikov, A. N., Zhang, G., Zeng, L., Kaur, J., Moy, G., Rusinova, E., Rodriguez, Y., Matikainen, B., Vincek, A., Joshua, J., Casaccia, P., & Zhou, M.-M.
Venue
Chemistry & Biology
Publisher
Elsevier BV
Published
2014-07
Volume
21
Issue
7
Pages
841-854
ISSN
1074-5521 (ISSN-L)
OpenAlex
W2091368230
Cited by
155
References
5
FWCI
4.75
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression. https://app.cochat.ai/papers/10.1016/j.chembiol.2014.05.009
The paper
Gacias, M., Gerona-Navarro, G., Plotnikov, A. N., Zhang, G., Zeng, L., Kaur, J., Moy, G., Rusinova, E., Rodriguez, Y., Matikainen, B., Vincek, A., Joshua, J., Casaccia, P., & Zhou, M.-M. (2014). Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression. Chemistry & Biology. https://doi.org/10.1016/j.chembiol.2014.05.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.